0.2081
前日終値:
$0.232
開ける:
$0.225
24時間の取引高:
3.27M
Relative Volume:
0.84
時価総額:
$1.78M
収益:
-
当期純損益:
$-7.35M
株価収益率:
-0.4524
EPS:
-0.46
ネットキャッシュフロー:
$-5.48M
1週間 パフォーマンス:
-23.77%
1か月 パフォーマンス:
-43.14%
6か月 パフォーマンス:
-81.25%
1年 パフォーマンス:
-47.99%
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
名前
Shuttle Pharmaceuticals Holdings Inc
セクター
電話
(240) 403-4212
住所
401 PROFESSIONAL DRIVE, GAITHERSBURG
SHPH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
0.2081 | 1.78M | 0 | -7.35M | -5.48M | -0.46 |
![]()
ZTS
Zoetis Inc
|
160.41 | 66.72B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
HLN
Haleon Plc Adr
|
10.45 | 47.91B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 47.74B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.48 | 18.80B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
308.07 | 13.47B | 2.76B | 1.11B | 898.10M | 22.77 |
Shuttle Pharmaceuticals Holdings Inc (SHPH) 最新ニュース
Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Certain Pre-Funded Warrants of Shuttle Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2025. - marketscreener.com
Shuttle Pharma’s glioblastoma trial reaches halfway mark By Investing.com - Investing.com Nigeria
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Shuttle Pharma’s glioblastoma trial reaches halfway mark - Investing.com
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial - GlobeNewswire
Did Shuttle Pharmaceuticals Holdings Inc (SHPH) perform well in the last session? - uspostnews.com
Market Resilience: Shuttle Pharmaceuticals Holdings Inc (SHPH) Finishes Weak at 0.27, Down -8.74 - DWinneX
Nothing is Better Than Shuttle Pharmaceuticals Holdings Inc (SHPH) stock at the moment - Sete News
Shuttle Pharmaceuticals Holdings Inc [SHPH] moved up 0.12: Why It’s Important - dbtnews.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Small Cap Stock Shuttle Pharmaceuticals Holdings Inc (SHPH) Is A Buy – Analysts - Marketing Sentinel
The Psychology of Shuttle Pharmaceuticals Holdings Inc Inc. (SHPH) Price Performance: Understanding Market Sentiment - investchronicle.com
A review of SHPH’s current quarter earnings predictions - uspostnews.com
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - GlobeNewswire
Shuttle Pharma's Latest Glioblastoma Trial Data and Cancer Diagnostic Advances: Key Updates Coming April 23 - Stock Titan
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why - Defense World
SHPH stock plunges to 52-week low of $0.33 amid steep annual decline - Investing.com India
Shuttle Pharma files patent for cancer treatment innovation By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer - marketscreener.com
Shuttle Pharma files patent for cancer treatment innovation - Investing.com Australia
Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer - marketscreener.com
Shuttle Pharma Developing Pretreatment Diagnostic Blood - GlobeNewswire
Game-Changing Prostate Cancer Treatment: Shuttle Pharma Unveils Breakthrough PSMA Technology - Stock Titan
Head to Head Analysis: Shuttle Pharmaceuticals (NASDAQ:SHPH) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023 - Seeking Alpha
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Shuttle Pharmaceuticals Appoints New Interim CEO and CSO - TipRanks
Shuttle Pharmaceuticals signs consulting deal with Bowery Group By Investing.com - Investing.com Australia
Shuttle Pharmaceuticals signs consulting deal with Bowery Group - Investing.com
Shuttle Pharmaceuticals Holdings IncOn March 21, Enters Consulting Agreement With Bowery ConsultingSEC Filing - Marketscreener.com
Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead - Asianet Newsable
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Up 3.8% – Should You Buy? - Defense World
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
SHPH stock touches 52-week low at $0.34 amid market challenges - Investing.com
SHPH stock touches 52-week low at $0.34 amid market challenges By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
SHPHSHUTTLE PHARMACTCLS HLDGS INC Latest Stock News & Market Updates - Stock Titan
Shuttle Pharma Announces Closing Of $5.75 Million Underwritten Offering -March 13, 2025 at 05:39 pm EDT - Marketscreener.com
Shuttle Pharma Secures $5.2M in Public Offering - TipRanks
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - GlobeNewswire
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - Benzinga
Shuttle Pharma Raises $5.75M: Strategic Boost for Revolutionary Cancer Treatment Trial - StockTitan
Shuttle Pharma appoints new interim co-CEO By Investing.com - Investing.com Australia
Shuttle Pharmaceuticals Holdings Inc (SHPH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):